starindia

starindia

New Listing: Sandhar Technologies lists at a premium of 5% at Rs 349

The stock listed at Rs 349, a gain of Rs 27 to the issue price of Rs 332 per share.Shares of Sandhar Technologies were listed at a premium of 5 percent on the exchanges here.The stock listed at Rs 349, a gain of Rs 27 to the issue price of Rs 332 per share. To…

0 reactions

Sun Pharma gains 3% on USFDA approval for psoriasis drug Ilumya

Ilumya is used for the treatment of the most common plaque psoriasis – a chronic immune disease that appears on the skin. Shares ofΒ Sun Pharmaceutical IndustriesΒ gained 3.4 percent in the early trade on Thursday as it has received USFDA approval for its psoriasis drug Ilumya. To Get Free Trial Missed call @Β 9582541010Β  Call Us @Β 8822117117 …

0 reactions